Content
All Posts > Content under Pharma/Biotech
Cannabis Central: 80% Of Stocks In Pure-Play Pot Portfolio Declined Again On Wednesday
Article By:
Lorimer Wilson
Read
Thursday, September 3, 2020 7:57 AM EDT
The Pure-Play Pot Stock Portfolio declined 2.4% on Wednesday with 20 (80%) of the stocks in the portfolio going down for the second day in a row as well as 3 of the 4 industry categories.
Wednesday Market Review
Article By:
Vivian Lewis
Read
Wednesday, September 2, 2020 8:26 PM EDT
As usual, there is good and bad news from our companies, and as usual with drug-makers in the lead.
In this article: GSK, RDY, RHHBY, GRFS, ESALY, BLRX, TEVA, CGEN, BNS, ANCUF, GRBMF, BGNE, ZYME, AQN, KL, NTR, BCE, GE, IBM, CGRIF, MSFT
Grains Report - Wednesday, September 2
Article By:
Jack Scoville
Read
Wednesday, September 2, 2020 1:24 PM EDT
Corn was slightly higher in reaction to more strong demand from China and deterioration in the Crop Progress and Condition reports due to the hot and dry weather seen in the Midwest last week.
Cannabis Central: 80% Of Stocks In Pure-Play Pot Stock Portfolio Declined Tuesday
Article By:
Lorimer Wilson
Read
Wednesday, September 2, 2020 8:38 AM EDT
The Pure-Play Pot Stock Portfolio consists of the 25 cannabis stocks that trade for +US$1/share and it declined 2.6%. A total of 80% of the stocks in the portfolio went down as well as all 4 of the industry categories.
Market Briefing For Wednesday, September 2
Article By:
Gene Inger
Read
Wednesday, September 2, 2020 3:53 AM EDT
The propensity of intensity - is amazing in the overly-exploited super-cap stocks. I realize we've addressed this behavior frequently, and it has been a proper backdrop to 'not fight the trend' and 'not fight the Fed'.
Cannabis Central: Pure-Play Pot Stock Portfolio Performance For Monday, August 31st
Article By:
Lorimer Wilson
Read
Tuesday, September 1, 2020 8:53 AM EDT
The Pure-Play Pot Stock Portfolio consists of the 25 pure-play cannabis stocks that trade for more than US$1/share and it advanced 0.3% on Monday. 10 stocks went up, 13 went down, 2 had no change in price.
Cannabis Central: Planet 13 Q2 Financials Hit Hard By Effects Of COVID-19
Article By:
Lorimer Wilson
Read
Tuesday, September 1, 2020 3:51 AM EDT
Planet 13 Q2 financial results, were hard hit by the COVID-19 pandemic. Since June, however, they have rebounded significantly with July and August experiencing the highest months of sales to date.
In this article: PLNHF
Profiting From Warren Buffett
Article By:
Vivian Lewis
Read
Monday, August 31, 2020 10:00 PM EDT
Buffett's new stake in five Japanese trading groups earned me a tidy profit. Meanwhile GSK and its partner Vir have begun enrolling people for the Comet-ICE antibody trial in phase II-III which expects to see results by the end of this year.
In this article: EXG, GSK, SLB, ITOCY, MARUF, SSUMY, HSNGF, MITSY, MSBHF, TMRAY, TEVA, CGEN, GLD, VEOEY, HMLP, KL, NOK, VOD, NIO, AZRE, BRK-A, BRK-B
There Is Beta In Protalix Stock Due To PRX-102
Article By:
Moon Kil Woong
Read
Monday, August 31, 2020 9:29 AM EDT
Protalix offers positive Beta on PRX-102 success.
